Articles published in Molecular Biomarkers & Diagnosis have been cited by esteemed scholars and scientists all around the world.
Molecular Biomarkers & Diagnosis has got h-index 19, which means every article in Molecular Biomarkers & Diagnosis has got 19 average citations.
Following are the list of articles that have cited the articles published in Molecular Biomarkers & Diagnosis.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
40 | 45 | 61 | 64 | 25 | 14 | 37 |
Research, Review articles and Editorials |
0 | 0 | 9 | 40 | 18 | 10 | 30 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
30 | 45 | 51 | 14 | 1 | 4 | 16 |
Conference proceedings |
0 | 0 | 7 | 0 | 0 | 25 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
2234 | 1605 | 182 | 206 | 253 | 221 | 222 |
Journal total citations count | 2054 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 5.42 |
Journal cite score | 5.28 |
Journal h-index | 19 |
Journal h-index since 2019 | 14 |
Phan, Phuc, Bibhuti Ballav Saikia, Shivakumar Sonnaila, Shilpi Agrawal, Zeina Alraawi, Thallapuranam Krishnaswamy Suresh Kumar, and Shilpa Iyer. "The Saga of Endocrine FGFs." Cells 10, no. 9 (2021): 2418. |
|
Fernandez, Sully. "The Effects of a High-Fat Diet on Mammary Gland Biology in a Model of Triple-Negative Breast Cancer." (2016). |
|
Feng, Tao, Jiahui Zhao, Dechao Wei, Pengju Guo, Xiaobing Yang, Qiankun Li, Zhou Fang et al. "Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer." Frontiers in immunology 12 (2021). |
|
Jin, Shi, Ning Xia, and Lingling Han. "Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes." BMJ Open Diabetes Research and Care 9, no. 1 (2021): e002126. |
|
Keerthiga, Rajendiran, De-Sheng Pei, and Ailing Fu. "Mitochondrial dysfunction, UPRmt signaling, and targeted therapy in metastasis tumor." Cell & Bioscience 11, no. 1 (2021): 1-14. |
|
Li, Tong, Bowen Wu, Tao Yang, Long Zhang, and Ke Jin. "BBA-Reviews on Cancer." |
|
Cardoso, A. L. "Towards frailty biomarkers Cardoso, Ana Luisa; Fernandes, Adelaide; Aguilar-Pimentel, Juan Antonio; de Angelis, Martin Hrab?; Guedes, Joana Ribeiro; Brito, Maria Alexandra; Ortolano, Saida; Pani, Giovambattista; Athanasopoulou, Sophia; Gonos, Efstathios S." (2018). |
|
Florea, Ana, Robin B. Harris, Yann C. Klimentidis, Lindsay N. Kohler, Peter W. Jurutka, and Elizabeth T. Jacobs. "Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma." Journal of Gastrointestinal Cancer 52, no. 3 (2021): 940-946. |
|
Gan, Feng, Jiafang Huang, Tianran Dai, Maorong Li, and Jinghua Liu. "Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification." Ann Palliat Med 9, no. 2 (2020): 368-374. |
|
Yu, Xiaofeng, Ying Li, Guodong Jiang, Jian Fang, Zhaolei You, Guangyuan Shao, Zheng Zhang, Aihong Jiao, and Xiaonu Peng. "FGF21 promotes non-small cell lung cancer progression by SIRT1/PI3K/AKT signaling." Life Sciences 269 (2021): 118875. |
|
Dai, Han, Wenjing Hu, Lianying Zhang, Feiyu Jiang, Xiongmin Mao, Gangyi Yang, and Ling Li. "FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway." Cell death & disease 12, no. 4 (2021): 1-12. |
|
Refsgaard Holm, Maria, Heidi Christensen, Jon Rasmussen, Marie Louise Johansen, Morten Schou, Jens Faber, and Caroline Kistorp. "Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation." ESC heart failure 6, no. 5 (2019): 983-991. |
|
Wang, Sheng-Fan, Shiuan Chen, Ling-Ming Tseng, and Hsin-Chen Lee. "Role of the mitochondrial stress response in human cancer progression." Experimental Biology and Medicine 245, no. 10 (2020): 861-878. |
|
Li, Jian?Ri, Kun?Yuan Chiu, Yen?Chuan Ou, Shian?Shiang Wang, Chuan?Su Chen, Cheng?Kuang Yang, Hao?Chung Ho et al. "Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma." BioFactors 45, no. 1 (2019): 62-68. |
|
Bandyopadhayaya, Shreetama, Bridget Ford, and Chandi C. Mandal. "Cold-hearted: a case for cold stress in cancer risk." Journal of Thermal Biology 91 (2020): 102608. |
|
Kang, Yea Eun, Jung Tae Kim, Mi Lim, Chan Oh, Lihua Liu, Seung-Nam Jung, Ho-Ryun Won et al. "Association between circulating fibroblast growth factor 21 and aggressiveness in thyroid cancer." Cancers 11, no. 8 (2019): 1154. |
|
Harlid, Sophia, Robin Myte, and Bethany Van Guelpen. "The metabolic syndrome, inflammation, and colorectal cancer risk: an evaluation of large panels of plasma protein markers using repeated, prediagnostic samples." Mediators of inflammation 2017 (2017). |
|
Lakhani, Ishan, Mengqi Gong, Wing Tak Wong, George Bazoukis, Konstantinos Lampropoulos, Sunny Hei Wong, William KK Wu et al. "Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis." Metabolism 83 (2018): 11-17. |
|
Chang, Joon Young, Hyon-Seung Yi, Hyeon-Woo Kim, and Minho Shong. "Dysregulation of mitophagy in carcinogenesis and tumor progression." Biochimica et Biophysica Acta (BBA)-Bioenergetics 1858, no. 8 (2017): 633-640. |
|
Yin, Jie, Wenkai Ren, Xingguo Huang, Tiejun Li, and Yulong Yin. "Protein restriction and cancer." Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869, no. 2 (2018): 256-262. |
|
Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report